Kronos Bio (NASDAQ:KRON) reported quarterly losses of $(0.59) per share. This is a 11.32 percent decrease over losses of $(0.53) per share from the same period last year.
Bank Of New York Mellon Beats Q2 Street Expectations
The Bank Of New York Mellon Corporation (NYSE: BK) reported